Copley Acquisition Corp has terminated its previously announced business combination with Ignite Proteomics, LLC. The termination was formalized on October 9, 2026, via a Mutual Termination of Business Combination Agreement.
The agreement was signed by Copley Acquisition Corp, Ignite Proteomics, LLC, Ignite Proteomics Holdings, Inc., and the respective merger subsidiaries. The termination is effective immediately and was executed pursuant to Section 8.1(a) of the original Business Combination Agreement, which was dated June 10, 2026.
Under the terms of the termination, all parties are released from further rights, remedies, or liabilities regarding the transaction, with the exception of specific provisions in Sections 6.14, 6.15, 8.2, 9.1, and Article X. Additionally, all ancillary documents, including Seller Support Agreements, Insider Letter Amendments, and Lock-Up Agreements, have been automatically terminated.
Copley Acquisition Corp stated its intention to continue pursuing a business combination. The company currently has until November 2, 2026, to consummate a new transaction, subject to potential extensions permitted by its organizational documents.
